Noona Ambartsumian

Noona Ambartsumian

Auto-generated profile, based on publicly available information

Noona Ambartsumian

Cancer Research Institute, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
MEMalin C Erlandsson
Malin C Erlandsson
MSMattias D. Svensson
Mattias D. Svensson
IJIng-Marie Jonsson
Ing-Marie Jonsson
LBLi Bian
Li Bian
NANoona Ambartsumian
Noona Ambartsumian
Maria I BokarewaMaria I Bokarewa
Maria I Bokarewa

1 May 2011 in Molecular Cancer Research
Verified
Journal Article
Open access
HMHenrik Devitt Møller
Henrik Devitt Møller
URUlrik Ralfkjær
Ulrik Ralfkjær
NCNatascha Cremers
Natascha Cremers
MFMika Frankel
Mika Frankel
RPRune Troelsgaard Pedersen
Rune Troelsgaard Pedersen
NANoona Ambartsumian
Noona Ambartsumian
The tumor microenvironment is now recognized as a major factor in determining the survival and growth of disseminated tumor cells at potential metastatic sites. Tumor cells send signals to stroma cells and stimulate them to produce factors that in turn create favorable conditions for tumor cell metastasis. Activated fibroblasts constitute an important component of the tumor-associated stroma. We have previously shown that S100A4 protein produced by stromal fibroblasts in the primary tumor stimulates metastasis formation. Here we show that activated fibroblasts also stimulate the formation of metastases independently of S100A4 expression during organ colonization. To identify genes that could potentially interfere with fibroblast-driven metastasis, we used gene expression profiling of S100A4-deficient fibroblasts treated with and without tumor cell-conditioned media. Five differentially expressed genes encoding cell surface and secreted proteins with potential metastasis-modulating activity were selected. Expression of lymphocyte antigen 6 complex (Ly6c) and matrix metalloproteinase 3 (Mmp3) was upregulated in fibroblasts in response to tumor-conditioned medium, whereas expression of cadherin-16 (Cdh16), Ccn2, and fibulin-5 (Fbln5) was downregulated. Further analysis showed that Fibulin-5 is able to suppress the metastatic colonization of lungs and liver. Additional studies suggest a mechanism in which Fibulin-5 suppresses metastasis formation by inhibiting production of matrix metalloproteinase 9 (MMP9) and reducing the invasive behavior of fibroblasts. Together our data are consistent with the notion that tumors secrete factors that downregulate expression of Fbln5 in fibroblasts at sites of metastatic colonization, in turn upregulating Mmp9 expression and stimulating metastatic organ colonization.